Our scientists have pioneered technology to analyze tumor DNA and shed light on the complex molecular changes that occur in cancer. These advances are also enabling our doctors to improve diagnoses and develop personalized treatments for patients. We now have extraordinary opportunities to provide insights into what causes cancers to form or progress and suggest strategies for blocking them.
Pictured: Surgical pathologist Jorge Reis-Filho uses DNA sequencing and functional genomics approaches to explore the biology of rare and aggressive forms of breast cancer, and to develop new treatments.
After oncologist Ross Levine was exposed to laboratory research in medical school, he decided to pursue a career as a physician-scientist. Now an assistant member in the Human Oncology and Pathogenesis Program, he analyzes the genetic makeup of cancer cells to identify disease pathways.